GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Finds High Prevalence of Poor Sleep Quality Among Critical Care Nurses Due to Work Demands

by GOAI
Share To

A recent systematic review and meta-analysis has identified a significant prevalence of poor sleep quality among nurses working in critical care units. The study, conducted by researchers Sanaie, Sarmadi, and Zare-Kaseb, examined data from multiple sources to assess the extent of sleep-related issues within this group. Findings indicate that critical care nurses frequently experience disrupted sleep patterns, which may be linked to the demanding nature of their work environment.

The research compiled and analyzed existing studies on the topic, revealing consistent evidence of widespread sleep disturbances among these healthcare professionals. Critical care nurses often face irregular work schedules, long shifts, and high-stress situations that contribute to poor sleep quality. The study underscores the potential implications for both nurse well-being and patient care outcomes. Researchers emphasize the need for further investigation into strategies that could mitigate these challenges and improve overall health for those in this field.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top